The Globe and Mail reports in its Friday edition that Aurora Cannabis is cleaning up a mess left behind by an investing site that erroneously published AI-written bumpf of non-existent business deals. The Globe's Dayne Patterson writes that an article posted on the Investing.com website Wednesday morning claimed Aurora had acquired New Zealand-based Medleaf Therapeutics in a cash-and-stock deal. The article specified the details of the purchase, quoted Aurora's chief executive officer, and cited a U.S. Securities and Exchange Commission filing as the source of its information. "To see the first article come out, no truth associated with it, on Investing.com -- which really, you know, obviously is not a credible source of information -- was concerning," Aurora CEO Miguel Martin told The Globe. Another article was published on the same website about eight hours later, outlining a purported partnership with a business called MediPharm GmbH, which also cited an SEC filing. There does not appear to be a company called MediPharm GmbH. However, there is an Austrian-based Meditrade-Medipharm GmbH and a Canadian company called MediPharm Labs, based in Barrie, Ont. "It's just an amazing piece of fiction," Mr. Martin said.